Correlation Between Aridis Pharmaceuticals and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aridis Pharmaceuticals and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Aridis Pharmaceuticals and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and Neurobo Pharmaceuticals.
Diversification Opportunities for Aridis Pharmaceuticals and Neurobo Pharmaceuticals
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Aridis and Neurobo is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aridis Pharmaceuticals and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Aridis Pharmaceuticals is expected to under-perform the Neurobo Pharmaceuticals. In addition to that, Aridis Pharmaceuticals is 2.12 times more volatile than Neurobo Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.03 per unit of volatility. If you would invest 1,320 in Neurobo Pharmaceuticals on September 3, 2024 and sell it today you would lose (1,084) from holding Neurobo Pharmaceuticals or give up 82.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 30.36% |
| Values | Daily Returns |
Aridis Pharmaceuticals vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Aridis Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Neurobo Pharmaceuticals |
Aridis Pharmaceuticals and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aridis Pharmaceuticals and Neurobo Pharmaceuticals
The main advantage of trading using opposite Aridis Pharmaceuticals and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Aridis Pharmaceuticals vs. Akari Therapeutics PLC | Aridis Pharmaceuticals vs. Aditxt Inc | Aridis Pharmaceuticals vs. ABVC Biopharma | Aridis Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |